Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11746120 Stat degraders and uses thereof

Patent 11746120 was granted and assigned to Kymera Therapeutics on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12077555 STAT degraders and uses thereof
0
Edits on 7 Sep, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Sep, 2023
Edits made to:
Infobox (+55 properties)
Article (+94 characters)
‌

 US Patent 11746120 Stat degraders and uses thereof

Article

The present invention provides compounds, compositions thereof, and methods of using the same.

Infobox
Is a
Patent
Patent
Patent Applicant
Kymera Therapeutics
Kymera Therapeutics
Current Assignee
Kymera Therapeutics
Kymera Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11746120
Patent Inventor Names
Bin Yang
Nan Ji
Nello Mainolfi
Yi Zhang
Date of Patent
September 5, 2023
Patent Application Number
18045390
Date Filed
October 10, 2022
Patent Citations
‌
US Patent 7173015 Inhibition of Syk kinase expression
‌
US Patent 7208157 Proteolysis targeting chimeric pharmaceutical
‌
US Patent 7273920 Controlling protein levels in eucaryotic organisms
‌
US Patent 7307077 Heterocyclic compound and antitumor agent containing the same as effective ingredient
‌
US Patent 7390799 Apoptosis promoters
‌
US Patent 7402325 Supercritical carbon dioxide extract of pharmacologically active components from
‌
US Patent 7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
‌
US Patent 7501496 Anti-OX40L antibodies
‌
US Patent 7514444 Inhibitors of bruton's tyrosine kinase
‌
US Patent 7528143 Bi-aryl meta-pyrimidine inhibitors of kinases
‌
US Patent 7557210 2,4-pyrimidinediamine compounds and their uses
‌
US Patent 7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
‌
US Patent 7622496 Modified lysine-mimetic compounds
‌
US Patent 7667039 1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase inhibitors
‌
US Patent 7713943 Further use of protein kinase N beta
‌
US Patent 7781433 Pharmaceutical compounds
‌
US Patent 7786142 Heterocyclic compounds as pSTAT3/IL-6 inhibitors
‌
US Patent 7932260 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
‌
US Patent 7960434 Small molecule inhibitors of STAT3 with anti-tumor activity
‌
US Patent 7989622 Phosphatidylinositol 3-kinase inhibitors and methods of their use
‌
US Patent 8138347 Quinoline derivatives as PI3 kinase inhibitors
‌
US Patent 8143412 Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)
‌
US Patent 8185616 Route designing method
‌
US Patent 8217035 Pyrimidine derivatives used as PI-3-kinase inhibitors
‌
US Patent 8263599 STAT3/5 activation inhibitor
‌
US Patent 8338439 2,4-disubstituted pyrimidines useful as kinase inhibitors
‌
US Patent 8446290 Self contained device for displaying electronic information
‌
US Patent 8486941 Phenyl amino pyrimidine compounds and uses thereof
‌
US Patent 8796320 1,3,4-Oxadiazole-2-carboxamide compound
‌
US Patent 8841257 Inhibitors of STAT3 and uses thereof
‌
US Patent 8883749 Transcription factor inhibitors and related compositions, formulations and methods
‌
US Patent 8906682 Methods for treatment of cancer
‌
US Patent 9500653 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
‌
US Patent 9632089 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
‌
US Patent 9694084 Methods to induce targeted protein degradation through bifunctional molecules
‌
US Patent 9750816 Methods to induce targeted protein degradation through bifunctional molecules
‌
US Patent 9770512 Methods to induce targeted protein degradation through bifunctional molecules
‌
US Patent 9821068 Methods to induce targeted protein degradation through bifunctional molecules
‌
US Patent 9969710 Heteroaryl compounds as IRAK inhibitors and uses thereof
‌
US Patent 10125114 Methods to induce targeted protein degradation through bifunctional molecules
‌
US Patent 10336744 1AP E3 ligase directed proteolysis targeting chimeric molecules
‌
US Patent 10874743 IRAK degraders and uses thereof
Patent Primary Examiner
‌
Po-Chih Chen

Find more entities like US Patent 11746120 Stat degraders and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo